2022
DOI: 10.31080/asps.2022.06.0845
|View full text |Cite
|
Sign up to set email alerts
|

Formulation and Evaluation of Floating Drug Delivery System for Oxcarbazepine

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
3
0

Year Published

2022
2022
2022
2022

Publication Types

Select...
1
1

Relationship

0
2

Authors

Journals

citations
Cited by 2 publications
(3 citation statements)
references
References 0 publications
0
3
0
Order By: Relevance
“…X 1 and X 2 stand for the main effect, X 1 X 2 are the interaction terms and shows how the response changes when two factors are simultaneously changed. X 1 2 and X 2 2 are quadratic terms of independent variables to evaluate nonlinearity.…”
Section: Methodmentioning
confidence: 99%
See 1 more Smart Citation
“…X 1 and X 2 stand for the main effect, X 1 X 2 are the interaction terms and shows how the response changes when two factors are simultaneously changed. X 1 2 and X 2 2 are quadratic terms of independent variables to evaluate nonlinearity.…”
Section: Methodmentioning
confidence: 99%
“…Thus, there are numerous advantages such as improved efficacy, reduced toxicity, improved patient compliance and convenience etc. 1,2 . Thus considerations have led to the development of oral controlled release CR dosage forms possessing gastric retention capabilities are the control of the location of a drug delivery system, especially for drugs exhibiting an absorption window in the GI tract or drugs with a stability problem, in a specific region of the GI tract offers several advantages 3 .…”
mentioning
confidence: 99%
“…Gastroretentive drug delivery system provides several benefits for drugs exhibiting poor bioavailability due to the narrow absorption window in the upper part of the gastrointestinal tract. As it retains the drug at the site of absorption and thus enhances the bioavailability and reducing the wastage of drug [1][2][3]. Theophylline, a methylxanthine drug used in the treatment of asthma, has narrow therapeutic index of 5-20 µg/ml serum concentrations.…”
Section: Introductionmentioning
confidence: 99%